These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 29611892)

  • 1. MLC901 (NeuroAiD II™) for cognition after traumatic brain injury: a pilot randomized clinical trial.
    Theadom A; Barker-Collo S; Jones KM; Parmar P; Bhattacharjee R; Feigin VL
    Eur J Neurol; 2018 Aug; 25(8):1055-e82. PubMed ID: 29611892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for Safety and Efficacy of MLC901 (NeuroAiD II) in Patients With Moderate Traumatic Brain Injury: A Randomized Double-Blind Placebo-Controlled Trial (ANDROMEDA).
    Chua AE; Yacapin VJ; Manalo GL; Ledesma LK
    Neurosurgery; 2023 Oct; 93(4):939-951. PubMed ID: 37129384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised, double-blind, placebo-controlled study investigating Safety and efficAcy of MLC901 in post-traUmatic bRAin Injury: the SAMURAI study protocol.
    Pilipenko P; Ivanova AA; Kotsiubinskaya YV; Feigin V; Majdan M; Grigoryeva VN; Khrulev AY
    BMJ Open; 2022 Apr; 12(4):e059167. PubMed ID: 35418437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NeuroAiD II (MLC901) in vascular cognitive impairment study (NEURITES).
    Chen CL; Ikram K; Anqi Q; Yin WT; Chen A; Venketasubramanian N;
    Cerebrovasc Dis; 2013; 35 Suppl 1():23-9. PubMed ID: 23548916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological outcome and its correlates in the first year after adult mild traumatic brain injury: A population-based New Zealand study.
    Barker-Collo S; Jones K; Theadom A; Starkey N; Dowell A; McPherson K; Ameratunga S; Dudley M; Te Ao B; Feigin V;
    Brain Inj; 2015; 29(13-14):1604-16. PubMed ID: 26382561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLC901, a Traditional Chinese Medicine induces neuroprotective and neuroregenerative benefits after traumatic brain injury in rats.
    Quintard H; Lorivel T; Gandin C; Lazdunski M; Heurteaux C
    Neuroscience; 2014 Sep; 277():72-86. PubMed ID: 24993477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT.
    Theadom A; Mahon S; Barker-Collo S; McPherson K; Rush E; Vandal AC; Feigin VL
    Eur J Neurol; 2013 Aug; 20(8):1135-44. PubMed ID: 23384428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The
    Chen CLH; Sharma PR; Tan BY; Low C; Venketasubramanian N
    Alzheimers Dement (N Y); 2019; 5():38-45. PubMed ID: 30723778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MLC901 in hypoxic-ischemic brain injury patients: A double-blind, randomized placebo-controlled pilot study.
    Pakdaman H; Gharagozli K; Karamiani F; Shamsi Goushki M; Moini S; Sobhanian A; Maghsoudlu F; Esfandani A; Hosseini MH; Amini Harandi A
    Medicine (Baltimore); 2023 Jun; 102(23):e33914. PubMed ID: 37335674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrolysin enhances cognitive recovery of mild traumatic brain injury patients: double-blind, placebo-controlled, randomized study.
    Chen CC; Wei ST; Tsaia SC; Chen XX; Cho DY
    Br J Neurosurg; 2013 Dec; 27(6):803-7. PubMed ID: 23656173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CHIMES-I: sub-group analyzes of the effects of NeuroAiD according to baseline brain imaging characteristics among patients randomized in the CHIMES study.
    Navarro JC; Chen CL; Lagamayo PD; Geslani MB; Eow GB; Poungvarin N; de Silva A; Wong LK; Venketasubramanian N;
    Int J Stroke; 2013 Aug; 8(6):491-4. PubMed ID: 23506216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational Medicine in Acute Ischemic Stroke and Traumatic Brain Injury-NeuroAiD Trials, from Traditional Beliefs to Evidence-Based Therapy.
    Venketasubramanian N; Yeo TT; Chen CLH
    Biomolecules; 2024 Jun; 14(6):. PubMed ID: 38927083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury.
    Goldstein FC; Caveney AF; Hertzberg VS; Silbergleit R; Yeatts SD; Palesch YY; Levin HS; Wright DW
    J Neurotrauma; 2017 Jan; 34(1):115-120. PubMed ID: 26973025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of extended-release methylphenidate following traumatic brain injury: a randomised controlled pilot study.
    Dymowski AR; Ponsford JL; Owens JA; Olver JH; Ponsford M; Willmott C
    Clin Rehabil; 2017 Jun; 31(6):733-741. PubMed ID: 27353245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylphenidate and Memory and Attention Adaptation Training for Persistent Cognitive Symptoms after Traumatic Brain Injury: A Randomized, Placebo-Controlled Trial.
    McDonald BC; Flashman LA; Arciniegas DB; Ferguson RJ; Xing L; Harezlak J; Sprehn GC; Hammond FM; Maerlender AC; Kruck CL; Gillock KL; Frey K; Wall RN; Saykin AJ; McAllister TW
    Neuropsychopharmacology; 2017 Aug; 42(9):1766-1775. PubMed ID: 27874023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury.
    McAllister TW; Zafonte R; Jain S; Flashman LA; George MS; Grant GA; He F; Lohr JB; Andaluz N; Summerall L; Paulus MP; Raman R; Stein MB
    Neuropsychopharmacology; 2016 Apr; 41(5):1191-8. PubMed ID: 26361060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Executive function training in chronic traumatic brain injury patients: study protocol.
    Krawczyk DC; Han K; Martinez D; Rakic J; Kmiecik MJ; Chang Z; Nguyen L; Lundie M; Cole RC; Nagele M; Didehbani N
    Trials; 2019 Jul; 20(1):435. PubMed ID: 31307502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based cohort study of the impacts of mild traumatic brain injury in adults four years post-injury.
    Theadom A; Starkey N; Barker-Collo S; Jones K; Ameratunga S; Feigin V;
    PLoS One; 2018; 13(1):e0191655. PubMed ID: 29385179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Out-of-Hospital Tranexamic Acid vs Placebo on 6-Month Functional Neurologic Outcomes in Patients With Moderate or Severe Traumatic Brain Injury.
    Rowell SE; Meier EN; McKnight B; Kannas D; May S; Sheehan K; Bulger EM; Idris AH; Christenson J; Morrison LJ; Frascone RJ; Bosarge PL; Colella MR; Johannigman J; Cotton BA; Callum J; McMullan J; Dries DJ; Tibbs B; Richmond NJ; Weisfeldt ML; Tallon JM; Garrett JS; Zielinski MD; Aufderheide TP; Gandhi RR; Schlamp R; Robinson BRH; Jui J; Klein L; Rizoli S; Gamber M; Fleming M; Hwang J; Vincent LE; Williams C; Hendrickson A; Simonson R; Klotz P; Sopko G; Witham W; Ferrara M; Schreiber MA
    JAMA; 2020 Sep; 324(10):961-974. PubMed ID: 32897344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial.
    Chen CLH; Lu Q; Moorakonda RB; Kandiah N; Tan BY; Villaraza SG; Cano J; Venketasubramanian N
    J Am Med Dir Assoc; 2022 Mar; 23(3):379-386.e3. PubMed ID: 34856171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.